J.P. Morgan Ventures Corp

This profile gathers the share dealings of J.P. Morgan Ventures Corp across 3 companies, led by Candela Corp /DE/, Cytogen Corp and Alpharma Inc. The record holds 78 filings, for trades running from 6 March 2007 to 9 October 2008.

On the open market, the record shows 63 purchases worth €7.6M and 14 sales worth €2.2M. Taken together, the purchases exceed the sales by €5.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2008: no purchases and 14 sales on the market.

In size, the median ticket on the buying side is €42k.

On 10 October 2008 came the latest disclosure, an open-market sale for €15k in Candela Corp /DE/. The latest purchase dates back some time: it was published 6,884 days ago, on 19 December 2007. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.